US Stock MarketDetailed Quotes

Denali Therapeutics (DNLI)

Watchlist
  • 20.160
  • +0.740+3.81%
Close Apr 14 16:00 ET
  • 20.160
  • 0.0000.00%
Post 20:01 ET
3.20BMarket Cap-6.79P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Denali Therapeutics (DNLI) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
10.65%555.34M
5.79%137.37M
11.57%137.43M
15.76%134.96M
10.08%145.58M
-4.81%501.88M
-2.06%129.85M
7.06%123.19M
-5.70%116.59M
-15.20%132.25M
Selling and administrative expenses
29.52%136.56M
31.28%39.46M
42.23%35.48M
28.07%32.27M
16.31%29.35M
2.02%105.44M
21.36%30.06M
-1.48%24.95M
-3.55%25.19M
-7.02%25.24M
-General and administrative expense
29.52%136.56M
31.28%39.46M
42.23%35.48M
28.07%32.27M
16.31%29.35M
2.02%105.44M
21.36%30.06M
-1.48%24.95M
-3.55%25.19M
-7.02%25.24M
Research and development costs
5.63%418.78M
-1.89%97.91M
3.78%101.95M
12.36%102.7M
8.61%116.23M
-6.47%396.44M
-7.44%99.79M
9.47%98.24M
-6.28%91.4M
-16.92%107.02M
Operating profit
-10.65%-555.34M
-5.79%-137.37M
-11.57%-137.43M
-15.76%-134.96M
-10.08%-145.58M
-155.15%-501.88M
2.06%-129.85M
-8.25%-123.19M
-168.39%-116.59M
-9.47%-132.25M
Net non-operating interest income expense
-33.62%42.9M
-41.18%8.92M
-34.15%10.53M
-38.27%10.84M
-20.76%12.61M
25.49%64.64M
15.48%15.16M
10.75%16M
36.18%17.57M
44.22%15.91M
Non-operating interest income
-33.62%42.9M
-41.18%8.92M
-34.15%10.53M
-38.27%10.84M
-20.76%12.61M
25.49%64.64M
15.48%15.16M
10.75%16M
36.18%17.57M
44.22%15.91M
Other net income (expense)
14.54M
0
14.54M
Special income (charges)
--0
--0
--0
--0
--0
--14.54M
--0
--0
--0
--14.54M
-Gain on sale of business
--0
--0
--0
--0
--0
--14.54M
--0
--0
--0
--14.54M
Income before tax
-21.23%-512.44M
-12.00%-128.45M
-18.39%-126.9M
-25.34%-124.12M
-30.62%-132.97M
-191.13%-422.71M
3.98%-114.69M
-7.89%-107.19M
-154.00%-99.03M
7.27%-101.8M
Income tax
50.00%102K
126.67%68K
Net income
-21.23%-512.54M
-12.02%-128.55M
-18.39%-126.9M
-25.34%-124.12M
-30.62%-132.97M
-191.12%-422.77M
3.95%-114.75M
-7.89%-107.19M
-154.00%-99.03M
7.27%-101.8M
Net income continuous Operations
-21.23%-512.54M
-12.02%-128.55M
-18.39%-126.9M
-25.34%-124.12M
-30.62%-132.97M
-191.12%-422.77M
3.95%-114.75M
-7.89%-107.19M
-154.00%-99.03M
7.27%-101.8M
Minority interest income
Net income attributable to the parent company
-21.23%-512.54M
-12.02%-128.55M
-18.39%-126.9M
-25.34%-124.12M
-30.62%-132.97M
-191.12%-422.77M
3.95%-114.75M
-7.89%-107.19M
-154.00%-99.03M
7.27%-101.8M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-21.23%-512.54M
-12.02%-128.55M
-18.39%-126.9M
-25.34%-124.12M
-30.62%-132.97M
-191.12%-422.77M
3.95%-114.75M
-7.89%-107.19M
-154.00%-99.03M
7.27%-101.8M
Basic earnings per share
-15.56%-2.97
-8.96%-0.73
-17.46%-0.74
-22.03%-0.72
-14.71%-0.78
-142.45%-2.57
22.09%-0.67
12.50%-0.63
-144.03%-0.59
15.00%-0.68
Diluted earnings per share
-15.56%-2.97
-8.96%-0.73
-17.46%-0.74
-22.03%-0.72
-14.71%-0.78
-142.45%-2.57
22.09%-0.67
12.50%-0.63
-145.38%-0.59
15.00%-0.68
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 10.65%555.34M5.79%137.37M11.57%137.43M15.76%134.96M10.08%145.58M-4.81%501.88M-2.06%129.85M7.06%123.19M-5.70%116.59M-15.20%132.25M
Selling and administrative expenses 29.52%136.56M31.28%39.46M42.23%35.48M28.07%32.27M16.31%29.35M2.02%105.44M21.36%30.06M-1.48%24.95M-3.55%25.19M-7.02%25.24M
-General and administrative expense 29.52%136.56M31.28%39.46M42.23%35.48M28.07%32.27M16.31%29.35M2.02%105.44M21.36%30.06M-1.48%24.95M-3.55%25.19M-7.02%25.24M
Research and development costs 5.63%418.78M-1.89%97.91M3.78%101.95M12.36%102.7M8.61%116.23M-6.47%396.44M-7.44%99.79M9.47%98.24M-6.28%91.4M-16.92%107.02M
Operating profit -10.65%-555.34M-5.79%-137.37M-11.57%-137.43M-15.76%-134.96M-10.08%-145.58M-155.15%-501.88M2.06%-129.85M-8.25%-123.19M-168.39%-116.59M-9.47%-132.25M
Net non-operating interest income expense -33.62%42.9M-41.18%8.92M-34.15%10.53M-38.27%10.84M-20.76%12.61M25.49%64.64M15.48%15.16M10.75%16M36.18%17.57M44.22%15.91M
Non-operating interest income -33.62%42.9M-41.18%8.92M-34.15%10.53M-38.27%10.84M-20.76%12.61M25.49%64.64M15.48%15.16M10.75%16M36.18%17.57M44.22%15.91M
Other net income (expense) 14.54M014.54M
Special income (charges) --0--0--0--0--0--14.54M--0--0--0--14.54M
-Gain on sale of business --0--0--0--0--0--14.54M--0--0--0--14.54M
Income before tax -21.23%-512.44M-12.00%-128.45M-18.39%-126.9M-25.34%-124.12M-30.62%-132.97M-191.13%-422.71M3.98%-114.69M-7.89%-107.19M-154.00%-99.03M7.27%-101.8M
Income tax 50.00%102K126.67%68K
Net income -21.23%-512.54M-12.02%-128.55M-18.39%-126.9M-25.34%-124.12M-30.62%-132.97M-191.12%-422.77M3.95%-114.75M-7.89%-107.19M-154.00%-99.03M7.27%-101.8M
Net income continuous Operations -21.23%-512.54M-12.02%-128.55M-18.39%-126.9M-25.34%-124.12M-30.62%-132.97M-191.12%-422.77M3.95%-114.75M-7.89%-107.19M-154.00%-99.03M7.27%-101.8M
Minority interest income
Net income attributable to the parent company -21.23%-512.54M-12.02%-128.55M-18.39%-126.9M-25.34%-124.12M-30.62%-132.97M-191.12%-422.77M3.95%-114.75M-7.89%-107.19M-154.00%-99.03M7.27%-101.8M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -21.23%-512.54M-12.02%-128.55M-18.39%-126.9M-25.34%-124.12M-30.62%-132.97M-191.12%-422.77M3.95%-114.75M-7.89%-107.19M-154.00%-99.03M7.27%-101.8M
Basic earnings per share -15.56%-2.97-8.96%-0.73-17.46%-0.74-22.03%-0.72-14.71%-0.78-142.45%-2.5722.09%-0.6712.50%-0.63-144.03%-0.5915.00%-0.68
Diluted earnings per share -15.56%-2.97-8.96%-0.73-17.46%-0.74-22.03%-0.72-14.71%-0.78-142.45%-2.5722.09%-0.6712.50%-0.63-145.38%-0.5915.00%-0.68
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +8.11%
Sample Name
Sample Code
 +7.67%
Sample Name
Sample Code
 +5.06%
4
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.18%
5
United States Gasoline Fund Lp
UGA
+2.58%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +26.23%
Sample Name
Sample Code
 +21.09%
Sample Name
Sample Code
 +18.00%
4
Hesai
HSAI
+16.00%
5
Futu Holdings Ltd
FUTU
+14.80%
View More
Middle East conflict spreads to the stock market! How should investors respond?
US President Trump stated in a recent interview that the US war with Iran has 'ended.' According to Axios, Pakistan, Egypt, and Turkey have Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -